Get the Stockscreener App
25.28
0.12%
0.03
Xoma Corporation stock is traded at $25.28, with a volume of 418.
It is up +0.12% in the last 24 hours and down -0.58% over the past month.
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
See More
Previous Close:
$25.25
Open:
$25.34
24h Volume:
418
Relative Volume:
0.15
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.28%
1M Performance:
-0.58%
6M Performance:
-1.31%
1Y Performance:
+1.12%
1-Day Range:
$25.28
$25.34
1-Week Range:
$24.74
$25.37
52-Week Range:
$23.32
$25.87
Xoma Corporation Stock (XOMAO) Company Profile
Name
Xoma Corporation
Sector
Industry
Phone
510 204 7200
Address
2200 Powell Street, Suite 310, EmeryVille
Compare XOMAO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XOMAO
Xoma Corporation
|
25.28 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
493.84 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
602.64 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
614.76 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.56 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
244.90 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Xoma Corporation Stock (XOMAO) Latest News
XOMA Co. (NASDAQ:XOMA) Shares Sold by Geode Capital Management LLC - Defense World
XOMA Royalty : 2025 Letter to Stockholders - marketscreener.com
How To Trade (XOMAP) - news.stocktradersdaily.com
Short Interest in XOMA Co. (NASDAQ:XOMAP) Drops By 15.9% - Defense World
Trading (XOMAO) With Integrated Risk Controls - news.stocktradersdaily.com
(XOMA) On The My Stocks Page - news.stocktradersdaily.com
Benchmark Begins Coverage on XOMA (NASDAQ:XOMA) - Defense World
Benchmark Initiates Coverage of XOMA Royalty CorporationPreferred Stock (XOMAP) with Buy Recommendation - Nasdaq
Benchmark Initiates Coverage of XOMA Royalty (LSE:0M26) with Buy Recommendation - Nasdaq
Benchmark Initiates Coverage of XOMA Royalty (XOMA) with Buy Recommendation - Nasdaq
Benchmark Initiates XOMA Royalty at Buy With $35 Price Target - marketscreener.com
XOMA Co. (NASDAQ:XOMAO) Sees Large Decrease in Short Interest - Defense World
XOMA Royalty (NASDAQ:XOMA) Is Making Moderate Use Of Debt - simplywall.st
Third Harmonic's shutdown, Coherus and Xoma drug sales connectedBizwomen - The Business Journals
Big moves by small biotechs signal potential shift for investorsSan Francisco Business Times - The Business Journals
XOMA Royalty Corporation's (NASDAQ:XOMA) Path To Profitability - Yahoo Finance
XOMA completes sale of Kinnate assets for up to $270 million By Investing.com - Investing.com South Africa
XOMA completes sale of Kinnate assets for up to $270 million - Investing.com Canada
Xoma Royalty Completes Sale Of Kinnate Pipeline Assets - MarketScreener
XOMA Royalty Completes Sale of Kinnate Pipeline Assets - GlobeNewswire
XOMA Co. (NASDAQ:XOMA) Director Joseph M. Limber Buys 17,935 Shares - MarketBeat
XOMA (NASDAQ:XOMA) Stock Rating Upgraded by StockNews.com - Defense World
XOMA Royalty Corp's chief investment officer purchases $49,400 in depositary shares By Investing.com - Investing.com India
XOMA Royalty Corp’s chief investment officer purchases $49,400 in depositary shares By Investing.com - Investing.com Canada
CIO’s Bold Move: A Major Investment in Xoma Stock - TipRanks
XOMA Royalty Corp Officer Acquires Additional Shares - TradingView
XOMA Royalty Corporation (XOMA): Among Stocks Insiders Bought in April After Trump’s Tariff Rollout - Insider Monkey
20 Stocks Insiders Bought in April After Trump’s Tariff Rollout - Insider Monkey
BioInvent Receives Milestone Payment as Takeda moves mezagitamab into Phase 3 - Yahoo Finance
XOMA Royalty Corporation's Preferreds Still Offer Attractive Yields With A Biotech Twist - Seeking Alpha
Director Makes Bold Move with Major Xoma Stock Purchase - TipRanks
XOMA stock touches 52-week low at $18.59 amid market shifts - Investing.com Australia
XOMA stock touches 52-week low at $18.59 amid market shifts By Investing.com - Investing.com South Africa
Xoma royalty director Joseph Limber purchases shares worth $760,144 By Investing.com - Investing.com South Africa
Xoma royalty director Joseph Limber purchases shares worth $760,144 - Investing.com
How to Take Advantage of moves in (XOMAP) - news.stocktradersdaily.com
XOMA (NASDAQ:XOMA) Rating Lowered to Sell at StockNews.com - Defense World
Top Executives Make Significant Moves in Xoma Stock! - TipRanks
Xoma royalty corp CFO buys $25k in depositary shares By Investing.com - Investing.com Canada
XOMA Royalty Corp’s chief investment officer acquires $26,200 in shares By Investing.com - Investing.com India
Xoma royalty corp CFO buys $25k in depositary shares - Investing.com
XOMA Royalty Corp Executives Increase Their Holdings - TradingView
XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference - The Manila Times
Key Investment Insights: XOMA CIO Takes Stage at Major Healthcare Conference - Stock Titan
Charles Schwab Investment Management Inc. Grows Stock Position in XOMA Co. (NASDAQ:XOMA) - Defense World
XOMA stock touches 52-week low at $19.9 amid market shifts - Investing.com India
Xoma Corporation Stock (XOMAO) Financials Data
There is no financial data for Xoma Corporation (XOMAO). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.24%
36.06%
Cap:
|
Volume (24h):